🇺🇸 FDA
Patent

US 9821019

Compositions and methods for treatment of pain

granted A61KA61K31/17A61K33/04

Quick answer

US patent 9821019 (Compositions and methods for treatment of pain) held by Princeton Biotechnology Corporation expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Princeton Biotechnology Corporation
Grant date
Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/17, A61K33/04, A61K33/38, A61K35/74